The First Discrete Choice Experiment On Usage of Bypassing Agents in Hemophilic Patients in Iran

نویسندگان
Habibpanah, Behnaz ID 1
Ardeshiri, Rezvan ID 2
Salimi, Tahmineh ID 3
Fasih, Belgheis ID 4
Tara, Zahra ID 5
Malek, Fatemeh ID 6
Managhchi, Mohammad Reza ID 7

1

2

3

4

5

6

7

doi
چکیده

Background: Bleeding events in hemophilic patients with inhibitors are managed by bypassing agents. Currently available agents in Iran are recombinant activated factor VII (rfVIIa; Aryogen, Aryoseven) and Feiba (factor eight inhibitor bypassing agent). No standardized and accurate assay is currently available for monitoring the effectiveness of bypassing agents. We suggested ...

کلیدواژه‌ها
Hemophilic patients, Patients’ response, Bypassing agents